GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology
22 Novembro 2024 - 11:09AM
Business Wire
- To help improve clinician workflow and visualization during
endoscopic bronchoscopy procedures, the company has added Lung
Suite to their OEC 3D m-CBCT offering.
- OEC Open interface expanded with additional third-party option
to streamline data interface during bronchoscopy procedures.
GE HealthCare (Nasdaq: GEHC) announces additional clinical
applications now available as part of the OEC 3D mobile CBCT C-arm
portfolio to help enable precise and efficient imaging during
endoscopic bronchoscopy procedures in the practice of
interventional pulmonology.
Complex pulmonary and thoracic procedures require precise
intraoperative imaging systems. To diagnose and biopsy a suspected
lesion or region of interest in the lungs, physicians need to
visualize and confirm the precise location of nodules and tools,
yet often the position of a nodule can differ from pre-operative CT
images because of the differences in respiratory patterns, patient
positioning, and other factors, resulting in CT to body divergence,
at time of the procedure.
GE HealthCare’s OEC 3D intraoperative mobile CBCT continues to
demonstrate imaging excellence and versatility for every day
procedures ranging from neuro-spine and orthopedic trauma to
interventional procedures, such as bronchoscopy.
Today’s announcement brings the following additions to the OEC
3D C-arm to help improve visualization of airways in the lungs
during bronchoscopy procedures:
OEC 3D Lung Suite: The OEC 3D enables clinicians to
visualize both 2D and 3D images of the lung using a single mobile
C-arm. For advanced imaging during endoscopy procedures, the OEC
3D Lung Suite includes:
- Augmented Fluoroscopy overlay of 3D points of interest on live
fluoroscopy images.
- Adjustable motorized 3D scan to accommodate patient or
equipment positions during a spin.
OEC Open: During bronchoscopy procedures, clinicians may
use navigation or robotic assistance, in addition to advanced
imaging, to reach the region of interest during the interventional
procedure. To help enable this workflow, OEC 3D C-arms provide an
OEC Open interface for automatically transferring 3D
volumetric data post reconstruction to verified navigation and
robotic systems.
A recent addition to the OEC Open offering is a verified
interface with the Intuitive Ion® Endoluminal Robotic
Bronchoscopy System (OS 1 v5.1.0 and later). This interface
enables users to automatically transfer OEC 3D mobile CBCT images
upon reconstruction to the Ion System to then update target
locations for clinician catheter adjustments during the
procedure.
GE HealthCare continues to expand OEC Open interfaces for a
variety of clinical procedures as an agnostic OEC Open ecosystem
for OEC 3D users. Today, OEC Open is verified with eight,
third-party systems spanning robotics, navigation, and augmented
reality vision.
“With Intuitive’s Ion Robotic Bronchoscopy System now verified
to interface with GE HealthCare’s OEC 3D through the OEC Open
interface, I believe we can now reach and diagnose almost any
nodule in the lung ,” shares Dr. Dominique Pepper, Medical Director
of Bronchoscopy and Respiratory Care, Providence Swedish South
Puget Sound.1 “This is a game-changer for clinicians - this can
help us confidently and accurately provide answers when we see a
suspicious area of interest.”
“As we continue to build out our OEC ecosystem, GE HealthCare is
excited about the addition of the Intuitive Ion robotic system to
our OEC Open interface,” shares Christian O’Connor – Global General
Manager for Surgery at GE HealthCare. “This interface provides
interventional pulmonologists using the OEC 3D C-arm a seamless
experience during minimally invasive, robotic-assisted bronchoscopy
procedures. Furthermore, this collaboration also signifies our
continued commitment to enabling surgeons access to the latest
technologies to support them in providing exceptional patient
care."
These latest additions build on the company’s continuous
innovation of the OEC C-arm portfolio to support clinicians in
their efforts to help improve the diagnosis, treatment, and overall
outcomes of their patients.
More about OEC 3D: First introduced in 2021, the OEC 3D
mobile CBCT C-arm provides precise 3D and 2D imaging every day in a
broad variety of procedures. During bronchoscopy procedures,
clinicians can leverage CBCT visualization features, such as Lung
Preset, to help optimize viewing of airway structures and Augmented
Fluoroscopy with Lung Suite to help confirm tool-in-lesion during a
procedure. While delivering exceptional image quality, the OEC 3D
also enables seamless transition from 3D to 2D imaging through one
versatile mobile CBCT imaging C-arm with an intuitive user
interface and workflow to help further optimize space in the
bronchoscopy suite.
Learn more at GEHealthCare.com.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 125 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Advanced Visualization Solutions,
Patient Care Solutions, and Pharmaceutical Diagnostics businesses
help improve patient care from diagnosis, to therapy, to
monitoring. We are a $19.6 billion business with approximately
51,000 colleagues working to create a world where healthcare has no
limits.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for
the latest news, or visit our website https://www.gehealthcare.com
for more information.
____________________________ 1 Paid Consultant: Dr. Dominique
Pepper is a paid consultant for GE HealthCare. The statements by
Dr. Dominique Pepper described here are based on his own opinions
and on results that were achieved in his unique setting. Since
there is no “typical” hospital and many variables exist, i.e.
hospital size, case mix, etc. there can be no guarantee that other
customers will achieve the same results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241121667735/en/
Eric Tatro Media Contact GE HealthCare
eric.tatro@gehealthcare.com
GE HealthCare Technologies (NASDAQ:GEHC)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
GE HealthCare Technologies (NASDAQ:GEHC)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024